Comparison of efficacy and the safety of insulin detemir and insulin NPH [neutral protamine Hagedorn] [insulin suspension isophane] as add-on to current OHA [oral hypoglycaemic agents] therapy in subjects with type 2 diabetes mellitus.
Phase of Trial: Phase III
Latest Information Update: 01 Feb 2017
At a glance
- Drugs Insulin detemir; Insulin suspension isophane
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 31 Aug 2018 Biomarkers information updated
- 01 Jul 2009 Actual patient number (362) added as reported by ClinicalTrials.gov.
- 01 Jul 2009 Actual end date (May 2005) added as reported by ClinicalTrials.gov.